These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 24060486)
21. Synthesis of novel nicotinohydrazide and (1,3,4-oxadiazol-2-yl)-6-(trifluoromethyl)pyridine derivatives as potential anticancer agents. Naresh Kumar R; Poornachandra Y; Nagender P; Santhosh Kumar G; Krishna Swaroop D; Ganesh Kumar C; Narsaiah B Bioorg Med Chem Lett; 2016 Oct; 26(19):4829-4831. PubMed ID: 27561719 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and cytotoxicity studies of novel pyrazolo[1, 5-a]pyridine derivatives. Ravi C; Qayum A; Chandra Mohan D; Singh SK; Adimurthy S Eur J Med Chem; 2017 Jan; 126():277-285. PubMed ID: 27889631 [TBL] [Abstract][Full Text] [Related]
23. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety. Abdel-Aziz HA; Saleh TS; El-Zahabi HS Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues. Yuan L; Song C; Li C; Li Y; Dong L; Yin S Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116 [TBL] [Abstract][Full Text] [Related]
25. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation. Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410 [TBL] [Abstract][Full Text] [Related]
26. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation. Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813 [TBL] [Abstract][Full Text] [Related]
27. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives. Nantka-Namirski P; Kaczmarek L Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557 [TBL] [Abstract][Full Text] [Related]
28. 3-Aminopyrazolo[3,4-b]pyridine: Effective Precursor for Barium Hydroxide-Mediated Three Components Synthesis of New Mono- and Bis(pyrimidines) with Potential Cytotoxic Activity. Sanad SMH; Mekky AEM Chem Biodivers; 2022 Jan; 19(1):e202100500. PubMed ID: 34784450 [TBL] [Abstract][Full Text] [Related]
29. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents. Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles. El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815 [TBL] [Abstract][Full Text] [Related]
31. Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells. Kim MH; Kim M; Yu H; Kim H; Yoo KH; Sim T; Hah JM Bioorg Med Chem; 2011 Mar; 19(6):1915-23. PubMed ID: 21353571 [TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity. Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents. Emmadi NR; Bingi C; Kotapalli SS; Ummanni R; Nanubolu JB; Atmakur K Bioorg Med Chem Lett; 2015 Aug; 25(15):2918-22. PubMed ID: 26048808 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma. Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity. Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety. Koca İ; Özgür A; Coşkun KA; Tutar Y Bioorg Med Chem; 2013 Jul; 21(13):3859-65. PubMed ID: 23664495 [TBL] [Abstract][Full Text] [Related]
37. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors. Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Ding XL; Zhang HY; Qi L; Zhao BX; Lian S; Lv HS; Miao JY Bioorg Med Chem Lett; 2009 Sep; 19(18):5325-8. PubMed ID: 19683442 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents. Abd El Hamid MK; Mihovilovic MD; El-Nassan HB Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities. Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]